LONDON (Alliance News) - Healthcare-focused advisory firm Cello Health PLC said Thursday it had a "strong" first-half performance with "good growth" in revenue and profit.
The company added that profit margins for the six months to June 30 were "slightly higher" than the same period a year ago.
The core Cello Health division saw half-year "excellent" like-for-like gross profit growth, the company said.
The company's Signal division "got off to a quick start to the year", after winning on projects and securing a good pipeline of future opportunities, the company added.
"The board is confident of achieving a successful result in 2018 in line with current market expectations," Cello said.
Cello Health shares were trading up 0.7% at 127.88 pence.
